Table 4.

Cost (€) due to healthcare utilization from 0 to 3 months, >3–6 months, >9–12 months and 0–12 months* (n=438)

	Patients with zero costs, n (%)	0–3 months		>3–6 months		>9–12 months		0–12 months*
		Mean (95% CI)†	Median (95% CI)†	Mean (95% CI)†	Median (95% CI)†	Mean (95% CI)†	Median (95% CI)†	Mean (95% CI)†	Median (95% CI)†
Primary care	83 (21)	199 (178 to 222)	116 (94 to 154)	138 (118 to 161)	43 (24 to 47)	120 (98 to 145)	0 (0 to 0)	458 (404 to 516)	242 (192 to 330)
Medication	176 (44)	19 (15 to 23)	0 (0 to 0.4)	17 (14 to 21)	0 (0 to 0)	16 (13 to 20)	0 (0 to 0)	52 (43 to 61)	3 (1 to 7)
Examination	308 (77)	31 (23 to 39)	0 (0 to 0)	15 (9 to 21)	0 (0 to 0)	19 (13 to 26)	0 (0 to 0)	65 (50 to 81)	0 (0 to 0)
Secondary care	390 (97)	33 (9 to 61)	0 (0 to 0)	90 (28 to 162)	0 (0 to 0)	120 (50 to 216)	0 (0 to 0)	243 (116 to 388)	0 (0 to 0)
Total	52 (13)	281 (244 to 322)	165 (165 to 165)	261 (189 to 346)	55 (46 to 55)	276 (195 to 370)	44 (23 to 46)	825 (682 to 976)	364 (307 to 440)

*Cost due to healthcare utilisation for the entire follow-up period is calculated on the basis for the three follow-up periods.

†Bias-corrected and accelerated bootstrapping (1000 simulations).